187 related articles for article (PubMed ID: 10496309)
1. Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states.
Yang XD; Corvalan JR; Wang P; Roy CM; Davis CG
J Leukoc Biol; 1999 Sep; 66(3):401-10. PubMed ID: 10496309
[TBL] [Abstract][Full Text] [Related]
2. Production of antigen-specific human antibodies from mice engineered with human heavy and light chain YACs.
Jakobovits A; Green LL; Hardy MC; Maynard-Currie CE; Tsuda H; Louie DM; Mendez MJ; Abderrahim H; Noguchi M; Smith DH; Zeng Y; David NE; Sasai H; Garza D; Brenner DG; Hales JF; McGuinness RP; Capon DJ; Klapholz S
Ann N Y Acad Sci; 1995 Sep; 764():525-35. PubMed ID: 7486581
[TBL] [Abstract][Full Text] [Related]
3. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice.
Mendez MJ; Green LL; Corvalan JR; Jia XC; Maynard-Currie CE; Yang XD; Gallo ML; Louie DM; Lee DV; Erickson KL; Luna J; Roy CM; Abderrahim H; Kirschenbaum F; Noguchi M; Smith DH; Fukushima A; Hales JF; Klapholz S; Finer MH; Davis CG; Zsebo KM; Jakobovits A
Nat Genet; 1997 Feb; 15(2):146-56. PubMed ID: 9020839
[TBL] [Abstract][Full Text] [Related]
4. Properties and pharmacokinetics of two humanized antibodies specific for L-selectin.
Co MS; Landolfi NF; Nagy JO; Tan JH; Vexler V; Vasquez M; Roark L; Yuan S; Hinton PR; Melrose J; Klingbeil C; Queen C; Berg EL
Immunotechnology; 1999 Mar; 4(3-4):253-66. PubMed ID: 10231094
[TBL] [Abstract][Full Text] [Related]
5. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.
Hart TK; Blackburn MN; Brigham-Burke M; Dede K; Al-Mahdi N; Zia-Amirhosseini P; Cook RM
Clin Exp Immunol; 2002 Oct; 130(1):93-100. PubMed ID: 12296858
[TBL] [Abstract][Full Text] [Related]
6. An anti-interleukin 8 monoclonal antibody that interferes with the binding of interleukin 8 to cellular receptors and the activation of human blood neutrophils.
Kurdowska A; Miller EJ; Cohen AB
Hybridoma; 1995 Jun; 14(3):225-33. PubMed ID: 7590784
[TBL] [Abstract][Full Text] [Related]
7. Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin.
Harada A; Sekido N; Kuno K; Akiyama M; Kasahara T; Nakanishi I; Mukaida N; Matsushima K
Int Immunol; 1993 Jun; 5(6):681-90. PubMed ID: 8347559
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Feldmann M; Maini RN
Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
[TBL] [Abstract][Full Text] [Related]
9. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library.
Ames RS; Tornetta MA; McMillan LJ; Kaiser KF; Holmes SD; Appelbaum E; Cusimano DM; Theisen TW; Gross MS; Jones CS
J Immunol; 1995 Jun; 154(12):6355-64. PubMed ID: 7759873
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
[TBL] [Abstract][Full Text] [Related]
12. Antigen-Specific Human Monoclonal Antibodies from Transgenic Mice.
Mompó SM; González-Fernández Á
Methods Mol Biol; 2019; 1904():253-291. PubMed ID: 30539474
[TBL] [Abstract][Full Text] [Related]
13. The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis.
Van Roy M; Ververken C; Beirnaert E; Hoefman S; Kolkman J; Vierboom M; Breedveld E; 't Hart B; Poelmans S; Bontinck L; Hemeryck A; Jacobs S; Baumeister J; Ulrichts H
Arthritis Res Ther; 2015 May; 17(1):135. PubMed ID: 25994180
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
[TBL] [Abstract][Full Text] [Related]
15. Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies.
Tomizuka K; Shinohara T; Yoshida H; Uejima H; Ohguma A; Tanaka S; Sato K; Oshimura M; Ishida I
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):722-7. PubMed ID: 10639146
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor.
Garrone P; Djossou O; Fossiez F; Reyes J; Ait-Yahia S; Maat C; Ho S; Hauser T; Dayer JM; Greffe J; Miossec P; Lebecque S; Rousset F; Banchereau J
Mol Immunol; 1996; 33(7-8):649-58. PubMed ID: 8760277
[TBL] [Abstract][Full Text] [Related]
17. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies.
Green LL
J Immunol Methods; 1999 Dec; 231(1-2):11-23. PubMed ID: 10648924
[TBL] [Abstract][Full Text] [Related]
18. Correlation of pharmacodynamic activity, pharmacokinetics, and anti-product antibody responses to anti-IL-21R antibody therapeutics following IV administration to cynomolgus monkeys.
Vugmeyster Y; Allen S; Szklut P; Bree A; Ryan M; Ma M; Spaulding V; Young D; Guay H; Bloom L; Leach MW; O'Toole M; Adkins K
J Transl Med; 2010 Apr; 8():41. PubMed ID: 20420683
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs.
Green LL; Hardy MC; Maynard-Currie CE; Tsuda H; Louie DM; Mendez MJ; Abderrahim H; Noguchi M; Smith DH; Zeng Y; David NE; Sasai H; Garza D; Brenner DG; Hales JF; McGuinness RP; Capon DJ; Klapholz S; Jakobovits A
Nat Genet; 1994 May; 7(1):13-21. PubMed ID: 8075633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
